22 Results for "

HLA-A2

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "HLA-A2" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-P10493
CAS No.: 202815-17-6
Research Areas:  

Cancer

NY-ESO-1 (157-165) peptide is a peptide fragment from NY-ESO-1 protein. NY-ESO-1 (157-165) peptide can activate the immune system, especially for HLA-A2 positive individuals, it can be recognized by CD8+ T cells, thus triggering an immune response. NY-ESO-1 (157-165) peptide is expressed in a variety of tumors and can be used as a target for tumor immunotherapy [2].
loading...
    loading...
Cat. No.: HY-P5470
CAS No.: 152274-91-4
Target:  

EBV IFNAR

Research Areas:  

Inflammation/Immunology

LMP2A (426-434) is a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope of Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A). LMP2A (426-434) can trigger an immune response in individuals expressing different HLA-A*02 subtypes (A*02:01, A*02:03, A*02:06 and A*02:07). LMP2A (426-434) can induce a strong IFN-γ secretion response, stimulating the production of a high proportion of CD8 + IFN-γ + T cells. LMP2A (426-434) induces specific CTLs to effectively kill target cells expressing LMP2A. LMP2A (426-434) can be used to study EBV-related malignant tumors (such as Hodgkin's disease and nasopharyngeal carcinoma) [2].
loading...
    loading...
Cat. No.: HY-P1778A
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas [2].
loading...
    loading...
Cat. No.: HY-P1919
CAS No.: 168650-46-2
Target:  

Tyrosinase

Research Areas:  

Cancer

Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy [2].
loading...
    loading...
Cat. No.: HY-P10493A
Research Areas:  

Cancer

NY-ESO-1 (157-165) peptide (TFA) is a peptide fragment from NY-ESO-1 protein. NY-ESO-1 (157-165) peptide (TFA) can activate the immune system, especially for HLA-A2 positive individuals, it can be recognized by CD8+ T cells, thus triggering an immune response. NY-ESO-1 (157-165) peptide (TFA) is expressed in a variety of tumors and can be used as a target for tumor immunotherapy [2].
loading...
    loading...
Cat. No.: HY-P1855
CAS No.: 160790-21-6
Target:  

EGFR

Research Areas:  

Cancer

HER2/neu (654-662) GP2 is a nine amino acid peptide derived from the human epidermal growth factor receptor 2 (HER2/nue, 654–662), induces HLA-A2-restricted cytotoxic T lymphocytes (CTL) reactive to various epithelial cancers [2].
loading...
    loading...
Cat. No.: HY-P991247

Target:  

MHC

Research Areas:  

Cancer

Anti-HLA-A2 (Hu8F4) is a human monoclonal antibody (mAb) targeting HLA-A2. Anti-HLA-A2 (Hu8F4) can be used in Acute myeloid leukaemia research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-P1700
CAS No.: 2293841-58-2
Target:  

TNF Receptor

Research Areas:  

Cancer

BCMA72-80 is a HLA-A2-specific B-cell maturation antigen (BCMA) peptide, with great affinity to HLA-A2, used in the research of multiple myeloma or other B-cell maturation antigen expressing tumors .
loading...
    loading...
Cat. No.: HY-106204
CAS No.: 160212-35-1
Synonyms: E75
Target:  

EGFR

Research Areas:  

Cancer

Nelipepimut-S (E75) is a peptide vaccine targeting HER2. When used in combination with granulocyte-macrophage colony-stimulating factor, Nelipepimut-S stimulates immune activity and induces anti-HER2 immune responses. Nelipepimut-S can be used in research related to breast cancer, triple-negative breast cancer and ductal carcinoma in situ [2].
loading...
    loading...
Cat. No.: HY-P1881
CAS No.: 160040-04-0
Target:  

HPV

Research Areas:  

Cancer

HPV16-E711-20 epitope is a well-known HLA-A *0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .
loading...
    loading...
Cat. No.: HY-P1778
CAS No.: 160212-93-1
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas [2].
loading...
    loading...
Cat. No.: HY-P4032
CAS No.: 160214-01-7
Target:  

HCV

Research Areas:  

Inflammation/Immunology

HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor .
loading...
    loading...
Cat. No.: HY-P3248
CAS No.: 444305-16-2
Synonyms: Myelin basic protein (85-99) antagonist
Research Areas:  

Inflammation/Immunology

J5 peptide is an MBP inhibitor that competitively inhibits the binding of MBP85-99 to HLA-DR2. J5 peptide alleviates PLP139-151/MBP85-99-induced experimental autoimmune encephalomyelitis (EAE) in mice. J5 peptide can be used in research on inflammatory and immune diseases .
loading...
    loading...
Cat. No.: HY-P2524
CAS No.: 160295-81-8
Target:  

Peptides

Research Areas:  

Cancer

MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta .
loading...
    loading...
Cat. No.: HY-106187
CAS No.: 156251-11-5
Research Areas:  

Cancer

MART-1 (27-35) (human) is the amino acid fragment spanning positions 27 to 35 of the MART-1 protein, and it represents an immunogenic epitope recognizable by HLA-A2-restricted melanoma-specific tumor-infiltrating lymphocytes (TILs). MART-1 (27-35) (human) can be used in studies related to melanoma [2].
loading...
    loading...
Cat. No.: HY-P991787

Target:  

MHC

Research Areas:  

Inflammation/Immunology Cancer

Anti-HLA-A2 Antibody (BB7.2) reacts with the alpha subunit of the human leukocyte antigen-A2 (HLA-A2). Recommend Isotype Controls: Mouse IgG2b kappa, Isotype Control (HY-P99982) .
loading...
    loading...
Cat. No.: HY-RS06206
Research Areas:  

Others

HLA-DQA2 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DQA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS06208
Research Areas:  

Others

HLA-DQB2 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DQB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P5294
CAS No.: 203515-09-7
Target:  

EBV

Research Areas:  

Cancer

YLLEMLWRL is an HLA-A2-restricted T cell epitope sequence corresponding to codon 125-133. Among them, YLLEMLWRL sequence is the main mutation site of HLA-A2-restricted CTL epitope sequence .
loading...
    loading...
Cat. No.: HY-P1914
CAS No.: 347142-73-8
Target:  

Peptides

Research Areas:  

Cancer

NY-BR-1 p904 (A2) is an HLA-A2-restricted NY-BR-1 epitope. T-cell clone specific for NY-BR-1 p904 can recognize breast tumor cells expressing NY-BR-1 .
loading...
    loading...